Skip to content
The Quiet LedgerBeyond the noise. On the record.
hr 1425 · 116th Congress · House

Patient Protection and Affordable Care Enhancement Act

—Sign in to watch / set alerts
TQL analysis
Not yet gradedThis bill has no published Quiet Ledger grade yet.
Legislative structure
Cosponsors
61 current · 61 total
Actions
23
Roll calls
2
Criterion breakdown8 criteria · max 90
No grade to break down.
Recorded vote · House roll call 124 · 2020-06-29
234 Yea · 179 Nay · 0 Present · 18 Not voting — Passed
D
232–1 (Yea–Nay)
R
2–176 (Yea–Nay)
L
0–1 (Yea–Nay)
I
0–1 (Yea–Nay)
Revealed positions from the official roll call — factual, not an endorsement.
Actions (23)
DateTimeAction
2019-02-28—Referred to the House Committee on Energy and Commerce.
2019-02-28—Introduced in House
2019-02-28—Introduced in House
2020-03-09—Placed on the Union Calendar, Calendar No. 334.
2020-03-09—Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-414.
2020-03-09—Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-414.
2020-06-2419:02:39Rules Committee Resolution H. Res. 1017 Reported to House. Rule provides for consideration of H.R. 1425, H.R. 5332, H.R. 7120, H.R. 7301 and H.J. Res. 90. The resolution provides that the provisions of section 125(c) of the Uruguay Round Agreements Act shall not apply during the remainder of the 116th Congress and the resolution amends H.Res. 967, agreed to on May 15, 2020.
2020-06-2910:11:44Considered under the provisions of rule H. Res. 1017. (consideration: CR H2599-2644)
2020-06-2910:11:49Rule provides for consideration of H.R. 1425, H.R. 5332, H.R. 7120, H.R. 7301 and H.J. Res. 90. The resolution provides that the provisions of section 125(c) of the Uruguay Round Agreements Act shall not apply during the remainder of the 116th Congress and the resolution amends H.Res. 967, agreed to on May 15, 2020.
2020-06-2910:13:11DEBATE - The House proceeded with three hours of debate on H.R. 1425.
2020-06-2913:59:46The previous question was ordered pursuant to the rule.
2020-06-2914:00:44Mr. Walden moved to recommit with instructions to the Committee on Energy and Commerce. (text: CR H2642-2643)
2020-06-2914:00:56Floor summary: DEBATE - The House proceeded with 10 minutes of debate on the Walden motion to recommit with instructions. The instructions contained in the motion seek to require the bill to be reported back to the House with an amendment to prevent the bill from taking effect unless the Secretary of Health and Human Services certifies that no provision of the bill would adversely affect research related to any drug intended to treat or prevent the virus that causes COVID-19.
2020-06-2914:08:54The previous question on the motion to recommit with instructions was ordered without objection.
2020-06-2914:09:28POSTPONED PROCEEDINGS - At the conclusion of debate on the motion to recommit with instructions, the Chair put the question on the motion and by voice vote, announced that the noes had prevailed. Mr. Walden demanded the yeas and nays and the Chair postponed further consideration on the motion to recommit until a time to be announced.
2020-06-2915:55:36Considered as unfinished business. (consideration: CR H2664-2665)
2020-06-2916:39:10On motion to recommit with instructions Failed by the Yeas and Nays: 187 - 223 (Roll no. 123).
2020-06-2917:18:42On passage Passed by the Yeas and Nays: 234 - 179 (Roll no. 124). (text: CR H2599-2614)
2020-06-2917:18:42Passed/agreed to in House: On passage Passed by the Yeas and Nays: 234 - 179 (Roll no. 124).
2020-06-2917:18:53Motion to reconsider laid on the table Agreed to without objection.
2020-06-30—Received in the Senate.
2020-08-13—Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
2020-09-08—Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 523.

The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.